Detalhe da pesquisa
1.
Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
Lancet Oncol
; 22(10): e435-e445, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592193
2.
The important role of the histopathologist in clinical trials: challenges and approaches to tackle them.
Histopathology
; 76(7): 942-949, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145084
3.
Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada.
Lancet Oncol
; 19(5): e267-e274, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29726391
4.
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Nat Genet
; 33(2): 162-7, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12524540
5.
Improving attribution of adverse events in oncology clinical trials.
Cancer Treat Rev
; 76: 33-40, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31108240
6.
Defining rare conditions in the era of personalized medicine.
Nat Rev Drug Discov
; 22(11): 857-858, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684343
7.
IRDiRC Drug Repurposing Guidebook: making better use of existing drugs to tackle rare diseases.
Nat Rev Drug Discov
; 22(12): 937-938, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872324
8.
Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage.
Mol Cell Biol
; 22(1): 78-93, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11739724
9.
To die or not to die: how does p53 decide?
Oncogene
; 23(16): 2809-18, 2004 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-15077144
10.
Eligibility criteria in haematological cancer clinical trials-what's needed?
Lancet Haematol
; 7(1): e10, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813851
11.
Additive intraocular pressure lowering effect of various medications with latanoprost.
Am J Ophthalmol
; 133(6): 836-7, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12036683
12.
Making medical education more affordable.
Ann Noninvasive Electrocardiol
; 14(1): 93-5, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19149799
13.
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes.
Nat Rev Drug Discov
; 18(10): 731-732, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570837
14.
Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
Nat Rev Drug Discov
; 18(7): 479-480, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940922
15.
Changing views on adverse event reporting.
Lancet Haematol
; 5(11): e506-e507, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907550